Analysts are intrested in these 5 stocks: ( (ABNB) ), ( (COP) ), ( (ALB) ), ( (TEM) ) and ( (UPST) ). Here is a breakdown of their recent ratings and the rationale behind them.
Claim 30% Off TipRanks
Forget margin or options. Here's how the pros trade TEMAirbnb is drawing fresh attention from analysts as new initiatives in the U.S. drive a meaningful acceleration in bookings. Phillip Securities’ Paul Chew has upgraded the stock to Buy with a target price of $138, citing a 12% jump in fourth-quarter revenue, stronger average daily rates, and the potential boost from major events like the Winter Olympics and the 2026 FIFA World Cup.
The firm highlights that nights and seats booked rose 10%, underpinned by programs such as Reserve Now, Pay Later, clearer fee structures, and updated cancellation policies that are resonating with guests. While near-term profits are being squeezed by higher marketing and product investment, Chew sees global expansion in markets like Latin America and Asia Pacific, where nights booked are growing in the mid-to-high teens, as a compelling long-term growth driver.
ConocoPhillips, by contrast, is losing a bit of its shine in the eyes of some analysts despite remaining a high-quality energy name. Leo Mariani has downgraded COP to Hold, arguing that the stock now trades at a premium valuation versus peers and that global oil prices may be near a short-term peak, limiting upside as the shares already sit near his $112 price target.
Mariani still points to COP’s strengths, including one of the best inventory lives in the sector, a low cost of supply with break-even below $50 WTI, and a strong balance sheet with modest leverage. He also notes the appeal of a roughly 3% dividend and buybacks that retire 3–4% of shares annually, but believes much of the future free cash flow growth, including the ramp from the Willow project in 2029, is already reflected in today’s valuation.
Albemarle is moving back into favor as the lithium market shows signs of structural healing rather than just speculative enthusiasm. Analyst Rock Hoffman has upgraded ALB to Buy with a new $190 target, arguing that lithium spot prices holding above $20/kg, combined with cost cuts and productivity gains, give the company powerful earnings leverage after a recent pullback from its highs.
Fourth-quarter results came in ahead of expectations, helped by strong energy storage volumes as destocking pressures eased across the supply chain. Hoffman now sees 2026 EBITDA margins expanding to about 41%, supported by $450 million of cost savings already in place and another $100–150 million targeted, while regulatory changes in China and stronger battery demand support a more constructive, albeit volatile, pricing environment for Albemarle’s portfolio.
Tempus AI, a newer name in public markets, is catching analyst interest as a high-growth play on precision medicine and healthcare data. Baird’s Catherine Ramsey Schulte has initiated coverage with a Buy (Outperform/Speculative Risk) rating and a $59 price target, emphasizing Tempus’s combination of genomics testing in oncology and a growing data and services business built around de-identified clinical information.
She argues that comprehensive genomic profiling remains underpenetrated and that Tempus is well placed as testing expands into earlier disease stages, more tumor types, and more reimbursed indications. With rich longitudinal, multimodal datasets and deep ties to providers and biopharma, Schulte models roughly 17% compound annual revenue growth through 2031 and sees meaningful upside from emerging areas like minimal residual disease testing and AI-driven diagnostics.
Upstart Holdings is also seeing a shift in sentiment as its long-term roadmap gives investors a clearer anchor for valuation. Analyst Giuliano Bologna has upgraded UPST to Hold from Sell, lifting his price target to $30 and noting that management’s 2025–2028 guidance for roughly 35% annual revenue growth and about 25% terminal EBITDA margins helps move the story from speculative swings to a more earnings-based debate.
Bologna still flags execution risk as Upstart scales auto loans and home equity products with newer economics, but his model suggests that if targets are met, the stock’s current multiples on 2028 tangible book and earnings could prove conservative. With new leadership set to take over in 2026, solid cash build projected through 2028, and a pivot toward more capital-efficient growth, Upstart is evolving into a name where future performance, rather than hype, could drive shareholder returns.